Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry
2019 · Inflammatory Bowel Diseases · 36 citations
https://doi.org/10.1093/ibd/izz084
M
Míriam Mañosa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
368
Papers
4.8K
Citations
39
h-index
104
i10-index
Míriam Mañosa is an academic researcher from Instituto de Salud Carlos III. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Helicobacter pylori-related gastroenterology studies. The author has an h-index of 39, co-authored 313 publications.
ORCID: 0000-0002-9051-2581Papers by this author
worksImpact of pain associated with the subcutaneous administration of adalimumab
2019 · Gastroenterología y Hepatología · 28 citations
https://doi.org/10.1016/j.gastrohep.2019.06.008
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre la importancia, el cribado y la vacunación en pacientes con enfermedad inflamatoria intestinal
2022 · Gastroenterología y Hepatología · 18 citations
https://doi.org/10.1016/j.gastrohep.2022.03.012
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU
2024 · Gut · 18 citations
https://doi.org/10.1136/gutjnl-2024-333385
IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management
2024 · Digestive Diseases and Sciences · 13 citations
https://doi.org/10.1007/s10620-023-08220-9
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
2022 · Frontiers in Medicine · 9 citations
https://doi.org/10.3389/fmed.2022.823900
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat